Nutrition education guided by Dietary Guidelines for Chinese Residents on metabolic syndrome characteristics, adipokines and inflammatory markers

Asia Pacific Journal of Clinical Nutrition

Volumn 20, Issue 1, 2011, Pages 77-86

  Zhang, Shi Xiu ^a,b   Guo, Hong Wei ^a   Wan, Wen Tao ^a   Xue, Kun ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Adiponectin; Leptin; Nutrition education; The metabolic Syndrome; Tumor necrosis factor

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; LEPTIN; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ATTITUDE TO HEALTH; BLOOD; BLOOD PRESSURE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; EXERCISE; FEMALE; HEALTH CARE POLICY; HUMAN; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL;

ADIPOKINES; ADIPONECTIN; ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHINA; DIET; EXERCISE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLAMMATION; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION POLICY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PATIENT EDUCATION AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955658330     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72:912-21.
2. Kerver JM, Yang EJ, Bianchi L, Song WO. Dietary patterns associated with risk factors for cardiovascular disease in healthy US adults. Am J Clin Nutr. 2003;78:1103-10.
3. Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens. 2006;24:621-6.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
5. Esposito K, Marfella R, Ciotola M, Palo CD, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292:1440-6.
6. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001;38:155.
7. Ard JD, Coffman CJ, Lin PH, Svetkey LP. One-year followup study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants. Am J Hypertens. 2004;17:1156-62.
8. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28:2823-31.
9. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4-12.
10. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-65.
11. Chinese Nutrition Society. The Dietary Guidelines for Chinese Residents. Tibet,China: Tibetan People's Publishing House; 2007. pp.175
12. Wang Guang-ya, Shen Zhi-ping, Fan Wen-xun. Food Composition. Beijing,China: People's Medical Publishing House; 1991.
13. Zhang Shi-xiu. Lipoprotein Lipase Gene-Diet Interaction in the Control of Metabolic Syndrome [dissertation]. Shanghai, China: Fudan University; 2010.
14. Li Yang. Study on Physical Activity Assessment in Urban Shanghai [dissertation]. Shanghai,China: Fudan University; 2004.
15. Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol. 2007;35:390-419.
16. Kim SM, Cho KH, Park HS. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr J. 2006;53:247-54.
17. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism. 2005;54: 476-81.
18. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol. 2006;26:871-6.
19. Zhang Shi-xiu, Guo Hong-wei., Wan Wen-tao, Xue Kun. Correlation of plasma adiponectin and components of metabolic syndrome. Chin J Prev Med. 2009;43:522-5.
20. Trujillo, ME, Scherer PE. Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257:167-75.
21. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671-4.
22. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade Creactive protein elevation. Eur J Endocrinol. 2003;148:657-62.
23. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
24. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 1995;38:764-71.
25. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-9.
26. Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc. 1998;57:413-9.
27. Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci U S A. 1997;94:4242-5.
28. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology. 1998;139:551-8.
29. Levy JR, Stevens W. The effects of insulin, glucose, and pyruvate on the kinetics of leptin secretion. Endocrinology. 2001;142:3558-62.
30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
31. Rizvi AA. Inflammation markers as mediators of vasculoendothelial dysfunction and atherosclerosis in the metabolic syndrome. Chin Med J (Engl). 2007;120:1918-24.
32. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233:674-88.
33. Bravata DM, Sanders L, Huang J, Krumholz HM, Olkin I, Gardner CD, Bravata D M. Efficacy and safety of lowcarbohydrate diets: a systematic review. JAMA. 2003;289: 1837-50.
34. Lissner L, Heitmann BL, Bengtsson C. Population studies of diet and obesity. Br J Nutr. 2007;83: S21-4.